India Pharma Outlook Team | Monday, 25 September 2023
ImageBiopsy Lab and Radiobotics have joined forces to improve the application of artificial intelligence (AI) enabled illness diagnoses in the DACH region for musculoskeletal (MSK), orthopaedic, and trauma use-cases. Musculoskeletal illnesses affect a bigger population than circulatory or respiratory diseases. Despite this, diagnostic approaches are frequently based on antiquated practices, such as manual interpretation of X-rays and MRI scans .
These subjective and time-consuming approaches are not standardised and rely on practitioner knowledge. Despite an increasing number of MSK-specific solutions, consumers lack a comprehensive solution for a wide range of diagnostic needs. ImageBiopsy Lab and Radiobotics both with MDR and FDA approvals will collaborate to deliver a single, comprehensive solution for MSK imaging that includes measuring, scoring, and fracture detection workflow. Dr. Richard Ljuhar, CEO and co-founder of ImageBiopsy Lab, explains, "Before even considering the use of AI, it's crucial to grasp physicians' diagnostic workflow and needs.
For this purpose we've closely collaborated with leading MSK radiologists, orthopaedics, and traumatologists over the past years. We're committed to revolutionizing the entire MSK diagnostic value chain for practitioners, patients, and healthcare systems. We see Radiobotics as the logical partner to offer best in class solutions for MSK conditions diagnostics, from measurements and scoring to fracture detection. Our collaboration marks the next AI-powered workflow integration phase, as per Vienna. Mads Jarner, CEO and co-founder of Radiobotics, notes, "As MSK AI solutions gain traction in clinical workflows, providing clinics with integrated and comprehensive options becomes vital. We're thrilled to collaborate with ImageBiopsy Lab to facilitate access to our market-leading solutions. Leveraging ImageBiopsy Lab's expertise and network in German-speaking regions, we're excited to introduce our RBfracture fracture detection solution in this area initially, with potential expansion to other regions.